| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Olian Judy D. is a Director at MAT with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | UTHR United Therapeutics Corporation | Director | Sell | 200 | $509.55 | $101,910.00 | -4.0% | - | - | |
| Sep 19, 2025 | UTHR United Therapeutics Corp | Director | Sell | 1,800 | $415.43 | $747,767.88 | -26.3% | +21.4% | - | |
| Nov 11, 2024 | UTHR United Therapeutics Corp | Director | Sell | 1,750 | $412.48 | $721,840.00 | -23.6% | -13.7% | +14.7% | |
| Jun 17, 2024 | UTHR United Therapeutics Corp | Director | Sell | 1,700 | $295.43 | $502,225.39 | -23.3% | +16.1% | -3.4% | |
| Jun 7, 2024 | ARES Ares Management Corp | Director | Sell | 3,417 | $134.00 | $457,864.67 | -11.1% | +6.1% | +30.8% | |
| May 3, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 10,000 | $258.56 | $2,585,601.35 | -15.7% | +24.9% | +12.3% | |
| Mar 12, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,000 | $248.20 | $1,241,006.38 | -15.2% | +11.5% | +24.4% | |
| May 23, 2023 | ARES Ares Management Corp | Director | Sell | 1,200 | $85.59 | $102,708.00 | -4.0% | +15.9% | +70.8% | |
| Jan 3, 2023 | UTHR United Therapeutics Corp | Director | Sell | 1,150 | $276.26 | $317,699.00 | -15.0% | -17.6% | -16.5% | |
| Dec 9, 2022 | UTHR United Therapeutics Corp | Director | Sell | 1,010 | $282.00 | $284,820.00 | -11.7% | -19.7% | -13.8% |